Ketamine and MDMA, two psychoactive substances that have gained notoriety as party drugs, are being increasingly recognised for their potential therapeutic applications in treating a range of mental health conditions. Despite their reputation as recreational drugs, these substances have shown promise in clinical trials as tools to address treatment-resistant depression, anxiety disorders and PTSD.

Join Dr. Ben Sessa to learn about the science and remarkable story behind ketamine and MDMA, both belonging to the psychedelic family. Ketamine is used to treat pain and has been found effective in treating mental health conditions such as depression and anxiety. MDMA-assisted psychotherapy is being studied as a safe and effective approach to treat lifelong mental disorders. This talk will highlight the recent psychedelic renaissance and draw on Dr. Ben Sessa’s 15 years of research and clinical work with psychedelics.

Doors open at 7pm, talk starts at 7.30pm – come down early to grab a drink and a good seat!

Follow us on IG @seedtalks

Online Tickets: We will email you a link for the event 24 hours before the stream and again 1 hour before it starts. Please ensure you remember which email address is associated with your eventbrite account, in order to check the correct inbox for the link.

Dr Ben Sessa has been at the forefront of psychedelic research in the UK through his affiliations with Imperial College London. Ben qualified as a medical doctor from UCL in 1997 and went on to specialise in psychiatry. Ben started studying psychedelics as a junior doctor, and has taken part in research projects at Bristol University, Cardiff University and Imperial College London with LSD, psilocybin, DMT, ketamine and MDMA – receiving and/or administering all of these compounds in legal research settings.